David Ghasemi
@davidrghasemi.bsky.social
Paediatric oncology resident @UKE Hamburg, Clinician Scientist @UKE Hamburg / KiTZ Heidelberg. Interested in paediatric #oncology, #neurooncology, and #genetics. Opinions are mine only.
I want to thank my co-first authors Katja von Hoff and Denise Obrecht-Sturm, the supervisors of this study, Kristian Pajtler and Stefan Rutkowski, and of course all other co-authors and especially our patients and their families. There is still a lot of work ahead of us! 3/3
October 8, 2025 at 5:35 PM
I want to thank my co-first authors Katja von Hoff and Denise Obrecht-Sturm, the supervisors of this study, Kristian Pajtler and Stefan Rutkowski, and of course all other co-authors and especially our patients and their families. There is still a lot of work ahead of us! 3/3
By incorporating molecular and clinical risk factors into one stratification model, we anticipate that our work will help to design the next generation of ependymoma trials. This was a complex and long-lasting, but also very rewarding project. 2/3
October 8, 2025 at 5:35 PM
By incorporating molecular and clinical risk factors into one stratification model, we anticipate that our work will help to design the next generation of ependymoma trials. This was a complex and long-lasting, but also very rewarding project. 2/3